SAN JOSE, May 6, 2026, 15:05 PDT
QuantumScape Corp. was grabbing the spotlight on Wednesday, with shares pushing up near $8 as traders circled back to the battery maker’s ongoing production ramp, customer testing updates, and the company’s persistent cash burn. The stock recently changed hands at $7.95—a 70 cent gain from the prior close—after hitting $7.99 earlier in the session.
This shift is crucial, marking a more intense chapter in QuantumScape’s lengthy commercialization push. The company’s focus now: getting its QSE-5 solid-state lithium-metal battery cells, which rely on solid materials and lithium metal for greater energy density versus standard lithium-ion tech, out of the pilot stage and into the hands of customers for field testing.
QuantumScape, in its first-quarter update, said cells from the Eagle Line pilot facility are now headed for “real-world test conditions.” Customer feedback comes next—critical for product tweaks. The Eagle Line in San Jose, a higher-volume pilot line, is designed to prove whether production can move past lab and small-batch scale.
Normal revenue? Not yet. In its April 24 quarterly filing, QuantumScape reported that planned principal operations remain on hold; as of March 31, the company still hadn’t generated any revenue from its main business activities.
Investors now zero in on operating milestones and the company’s “customer billings” figure—a metric tracking invoices sent out to customers and partners, not to be confused with revenue as defined by U.S. accounting rules. Chief Financial Officer Kevin Hettrich clarified for investors that it’s “not a substitute for revenue under US GAAP.” Investing.com
QuantumScape posted a net loss of $100.8 million for the first quarter, alongside an adjusted EBITDA loss of $63.2 million. That adjusted EBITDA figure strips out interest, taxes, depreciation, amortization, and various other items. The company stuck to its full-year outlook: adjusted EBITDA loss still seen between $250 million and $275 million, with capital expenditures expected in the $40 million to $60 million range.
QuantumScape has finished installing the Eagle Line and kicked off operations, according to Chief Executive Siva Sivaram on the April call. The company, he said, is now “producing initial volumes of QSE-5 cells.” For the second quarter, Sivaram flagged a push to scale up production, aiming to back customer programs across automotive and other sectors. Investing.com
The company kept collaborating with Volkswagen Group’s PowerCo, sent out cells to an automotive joint-development partner for testing, and wrapped up a tech evaluation with yet another top-10 global automaker. “All told, that’s four of the top 10” automakers involved in its auto pipeline, Sivaram said. Investing.com
QuantumScape is pushing to expand its story past electric vehicles. The company has told shareholders there’s interest from AI data centers, defense, aerospace, and government circles. Its partners Murata Manufacturing and Corning are both involved in ceramic separator production. Jamie Huang-Chu, program director of energy materials at Corning, described the company as “optimistic” about helping to deliver “a better battery at a competitive price.”
Time’s tight for solid-state battery players. Solid Power on Tuesday reported it wrapped up site acceptance testing for an SK On pilot cell line, delivered electrolyte to Samsung SDI as part of its joint evaluation project with BMW, and said its own sulfide-electrolyte pilot line remains set for end-2026 commissioning. Both Toyota and Sumitomo Metal Mining have said they’re pushing to make all-solid-state batteries feasible for EVs. Toyota’s aiming for either 2027 or 2028.
Scale is the real challenge here, not just the technical hurdles. Solid-state batteries are supposed to deliver safer, longer-lasting, and quicker-charging options, but as Reuters has noted, major barriers remain: supply constraints on raw materials, tough production processes, and steep costs. If QuantumScape hits snags in field tests, gets lackluster customer reactions, or sees patchy revenue from its partners, it’ll be tough to justify the stock’s recent jump.
On Wednesday, a different Form 144 appeared, disclosing plans for a possible sale of 50,000 common shares related to restricted stock vesting. The document signals intent to resell, but doesn’t confirm any actual share sales.
